Ne DHHS HAN | Update: COVID-19 therapeutics updates & shortages of oseltamivir, amoxicillin, & amoxicillin-clavulanate
On November 7, 2022, Ne DHHS released a HAN regarding COVID-19 therapeutics updates & shortages of
oseltamivir, amoxicillin, & amoxicillin-clavulanate.
Find out more at: https://dhhs.ne.gov/han%20Documents/UPDATE12082022.pdf
Sign up for Email Updates
When malaria is a diagnostic consideration in a patient with suspected viral hemorrhagic fever (VHF), frontline teams face important questions about testing, laboratory safety, and clinical care.
Join NETEC on November 18 at 1 p.m. ET for “Malaria and VHF: Navigating Testing and Clinical Decision-Making in the Frontline Setting.”
Through real-world case studies from Denver Health, expert panelists will discuss testing options, specimen handling, interpretation of results, possible coinfection, and considerations for presumptive treatment.
Panelists include:
• Vicki Herrera, MS — University of Nebraska Medical Center - UNMC
• David Richards, MD, FACEP — University of Colorado School of Medicine and Denver Health Medical Center
• Sarah Turbett, MD — Mass General Brigham and Massachusetts General Hospital
• Heather Young, MD — University of Colorado Anschutz School of Medicine and Denver Health
Moderated by Anna Yaffee, MD, MPH, of Emory University.
The session includes audience Q&A. Continuing education credit will be provided.
Register and submit your questions: https://unmc.zoom.us/webinar/register/9017919227010/WN_wD7CHXwtSJi1_6HEsBvtGg#/registration
Join NETEC on November 18 at 1 p.m. ET for “Malaria and VHF: Navigating Testing and Clinical Decision-Making in the Frontline Setting.”
Through real-world case studies from Denver Health, expert panelists will discuss testing options, specimen handling, interpretation of results, possible coinfection, and considerations for presumptive treatment.
Panelists include:
• Vicki Herrera, MS — University of Nebraska Medical Center - UNMC
• David Richards, MD, FACEP — University of Colorado School of Medicine and Denver Health Medical Center
• Sarah Turbett, MD — Mass General Brigham and Massachusetts General Hospital
• Heather Young, MD — University of Colorado Anschutz School of Medicine and Denver Health
Moderated by Anna Yaffee, MD, MPH, of Emory University.
The session includes audience Q&A. Continuing education credit will be provided.
Register and submit your questions: https://unmc.zoom.us/webinar/register/9017919227010/WN_wD7CHXwtSJi1_6HEsBvtGg#/registration
9.7 million infections. 50,800 deaths. Every year.
That’s the estimated U.S. toll of the drug-resistant bacteria and fungi in CDC’s 2026 AR Threats Report.
The report names 19 pathogens as urgent, serious or concerning threats. Six more are on a Watch List. It’s now a website, so the data will be updated more often.
Infection preventionists see this work up close. Now you have the numbers to back it.
Explore the report: https://hubs.li/Q04CwNR60
#CDCARThreats #InfectionPrevention #AntimicrobialResistance
That’s the estimated U.S. toll of the drug-resistant bacteria and fungi in CDC’s 2026 AR Threats Report.
The report names 19 pathogens as urgent, serious or concerning threats. Six more are on a Watch List. It’s now a website, so the data will be updated more often.
Infection preventionists see this work up close. Now you have the numbers to back it.
Explore the report: https://hubs.li/Q04CwNR60
#CDCARThreats #InfectionPrevention #AntimicrobialResistance